Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912665760> ?p ?o ?g. }
- W2912665760 endingPage "1271" @default.
- W2912665760 startingPage "1255" @default.
- W2912665760 abstract "Renin-angiotensin aldosterone system inhibitors are for a long time extensively used for the treatment of cardiovascular and renal diseases. AT1 receptor blockers (ARBs or sartans) act as antihypertensive drugs by blocking the octapeptide hormone Angiotensin II to stimulate AT1 receptors. The antihypertensive drug candesartan (CAN) is the active metabolite of candesartan cilexetil (Atacand, CC). Complexes of candesartan and candesartan cilexetil with 2-hydroxylpropyl-β-cyclodextrin (2-HP-β-CD) were characterized using high-resolution electrospray ionization mass spectrometry and solid state 13C cross-polarization/magic angle spinning nuclear magnetic resonance (CP/MAS NMR) spectroscopy. The 13C CP/MAS results showed broad peaks especially in the aromatic region, thus confirming the strong interactions between cyclodextrin and drugs. This experimental evidence was in accordance with molecular dynamics simulations and quantum mechanical calculations. The synthesized and characterized complexes were evaluated biologically in vitro. It was shown that as a result of CAN's complexation, CAN exerts higher antagonistic activity than CC. Therefore, a formulation of CC with 2-HP-β-CD is not indicated, while the formulation with CAN is promising and needs further investigation. This intriguing result is justified by the binding free energy calculations, which predicted efficient CC binding to 2-HP-β-CD, and thus, the molecule's availability for release and action on the target is diminished. In contrast, CAN binding was not favored, and this may allow easy release for the drug to exert its bioactivity." @default.
- W2912665760 created "2019-02-21" @default.
- W2912665760 creator A5003292804 @default.
- W2912665760 creator A5005571764 @default.
- W2912665760 creator A5013966275 @default.
- W2912665760 creator A5015546229 @default.
- W2912665760 creator A5019014253 @default.
- W2912665760 creator A5022832992 @default.
- W2912665760 creator A5023152624 @default.
- W2912665760 creator A5024188443 @default.
- W2912665760 creator A5025197550 @default.
- W2912665760 creator A5028521973 @default.
- W2912665760 creator A5033947135 @default.
- W2912665760 creator A5038339768 @default.
- W2912665760 creator A5048998007 @default.
- W2912665760 creator A5055327885 @default.
- W2912665760 creator A5062381896 @default.
- W2912665760 creator A5064918320 @default.
- W2912665760 creator A5065487450 @default.
- W2912665760 creator A5072989657 @default.
- W2912665760 creator A5078962467 @default.
- W2912665760 creator A5079942507 @default.
- W2912665760 creator A5080235407 @default.
- W2912665760 creator A5081215916 @default.
- W2912665760 creator A5090891795 @default.
- W2912665760 date "2019-01-25" @default.
- W2912665760 modified "2023-10-04" @default.
- W2912665760 title "Host–Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism" @default.
- W2912665760 cites W1031578623 @default.
- W2912665760 cites W1968984443 @default.
- W2912665760 cites W1976161355 @default.
- W2912665760 cites W1976499671 @default.
- W2912665760 cites W1985588649 @default.
- W2912665760 cites W1988683629 @default.
- W2912665760 cites W2000815209 @default.
- W2912665760 cites W2004372387 @default.
- W2912665760 cites W2013143504 @default.
- W2912665760 cites W2016714221 @default.
- W2912665760 cites W2019832473 @default.
- W2912665760 cites W2019898247 @default.
- W2912665760 cites W2021565138 @default.
- W2912665760 cites W2021832765 @default.
- W2912665760 cites W2022729267 @default.
- W2912665760 cites W2026514064 @default.
- W2912665760 cites W2029734694 @default.
- W2912665760 cites W2037803157 @default.
- W2912665760 cites W2038997848 @default.
- W2912665760 cites W2042257216 @default.
- W2912665760 cites W2043666236 @default.
- W2912665760 cites W2043812489 @default.
- W2912665760 cites W2058363175 @default.
- W2912665760 cites W2065791710 @default.
- W2912665760 cites W2069585066 @default.
- W2912665760 cites W2073444022 @default.
- W2912665760 cites W2073637781 @default.
- W2912665760 cites W2074631079 @default.
- W2912665760 cites W2095153694 @default.
- W2912665760 cites W2098943363 @default.
- W2912665760 cites W2106140689 @default.
- W2912665760 cites W2118233996 @default.
- W2912665760 cites W2119463481 @default.
- W2912665760 cites W2141273392 @default.
- W2912665760 cites W2147993766 @default.
- W2912665760 cites W2148284063 @default.
- W2912665760 cites W2155798859 @default.
- W2912665760 cites W2313116527 @default.
- W2912665760 cites W2313569107 @default.
- W2912665760 cites W2320736566 @default.
- W2912665760 cites W2332712348 @default.
- W2912665760 cites W2471778072 @default.
- W2912665760 cites W2618133162 @default.
- W2912665760 cites W2952958299 @default.
- W2912665760 cites W3004982183 @default.
- W2912665760 doi "https://doi.org/10.1021/acs.molpharmaceut.8b01212" @default.
- W2912665760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30681344" @default.
- W2912665760 hasPublicationYear "2019" @default.
- W2912665760 type Work @default.
- W2912665760 sameAs 2912665760 @default.
- W2912665760 citedByCount "17" @default.
- W2912665760 countsByYear W29126657602020 @default.
- W2912665760 countsByYear W29126657602021 @default.
- W2912665760 countsByYear W29126657602022 @default.
- W2912665760 countsByYear W29126657602023 @default.
- W2912665760 crossrefType "journal-article" @default.
- W2912665760 hasAuthorship W2912665760A5003292804 @default.
- W2912665760 hasAuthorship W2912665760A5005571764 @default.
- W2912665760 hasAuthorship W2912665760A5013966275 @default.
- W2912665760 hasAuthorship W2912665760A5015546229 @default.
- W2912665760 hasAuthorship W2912665760A5019014253 @default.
- W2912665760 hasAuthorship W2912665760A5022832992 @default.
- W2912665760 hasAuthorship W2912665760A5023152624 @default.
- W2912665760 hasAuthorship W2912665760A5024188443 @default.
- W2912665760 hasAuthorship W2912665760A5025197550 @default.
- W2912665760 hasAuthorship W2912665760A5028521973 @default.
- W2912665760 hasAuthorship W2912665760A5033947135 @default.
- W2912665760 hasAuthorship W2912665760A5038339768 @default.
- W2912665760 hasAuthorship W2912665760A5048998007 @default.
- W2912665760 hasAuthorship W2912665760A5055327885 @default.